This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

With respect to both the article by Harrison et al¹ and the Editorial by Liebowitz² regarding outpatient strategies in the management of venous thromboembolism (VTE) using low-molecular-weight heparin (LMWH), the onus has shifted to the outpatient arena as the first consideration for treatment. Consideration was given to inpatient treatment only if conditions arose that increased bleeding risk, were associated with significant comorbidity, and incurred mental and physical restrictions to home treatment. Harrison et al found that more than 75% of all patients (89 of 113) with deep venous thrombosis (DVT) were treated at home. Other manifestations of VTE such as upper extremity DVT and pulmonary embolism (PE) were also included in the home treatment program. The rate of recurrent disease and major bleeding was 6% and 1%, respectively, and the home treatment program was associated with a high degree of patient satisfaction.

The problem should be stated in a different . . . [Full Text of this Article]

RELATED ARTICLES

Deep Venous Thrombosis: Thinking Inside Out
Richard S. Liebowitz
Arch Intern Med. 1998;158(18):1964.
EXTRACT | FULL TEXT  

Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin
Linda Harrison, Joanne McGinnis, Mark Crowther, Jeffrey Ginsberg, and Jack Hirsh
Arch Intern Med. 1998;158(18):2001-2003.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antithrombotic Therapy Practices in US Hospitals in an Era of Practice Guidelines
Tapson et al.
Arch Intern Med 2005;165:1458-1464.
ABSTRACT | FULL TEXT  

Cost for Inpatient Care of Venous Thrombosis: A Trial of Enoxaparin vs Standard Heparin
de Lissovoy et al.
Arch Intern Med 2000;160:3160-3165.
ABSTRACT | FULL TEXT  

Effectiveness and Economic Impact Associated With a Program for Outpatient Management of Acute Deep Vein Thrombosis in a Group Model Health Maintenance Organization
Tillman et al.
Arch Intern Med 2000;160:2926-2932.
ABSTRACT | FULL TEXT